Search by Drug Name or NDC
NDC 71399-4458-06 AsperFlex Advance 86.24; 166.92; 278.2 mg/1; mg/1; mg/1 Details
AsperFlex Advance 86.24; 166.92; 278.2 mg/1; mg/1; mg/1
AsperFlex Advance is a PERCUTANEOUS; TOPICAL; TRANSDERMAL PATCH in the HUMAN OTC DRUG category. It is labeled and distributed by Akron Pharma Inc.. The primary component is CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE.
Product Information
| NDC | 71399-4458 |
|---|---|
| Product ID | 71399-4458_77265a35-9fb8-40a4-a069-12037a505e1d |
| Associated GPIs | 90809903255935 |
| GCN Sequence Number | 085502 |
| GCN Sequence Number Description | methyl salicylate/menth/camph ADH. PATCH 10 %-6 % TOPICAL |
| HIC3 | L6A |
| HIC3 Description | IRRITANTS/COUNTER-IRRITANTS |
| GCN | 55004 |
| HICL Sequence Number | 002581 |
| HICL Sequence Number Description | METHYL SALICYLATE/MENTHOL/CAMPHOR |
| Brand/Generic | Generic |
| Proprietary Name | AsperFlex Advance |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Camphor, Menthol, Methyl salicylate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | PATCH |
| Route | PERCUTANEOUS; TOPICAL; TRANSDERMAL |
| Active Ingredient Strength | 86.24; 166.92; 278.2 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE |
| Labeler Name | Akron Pharma Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part348 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71399-4458-06 (71399445806)
| NDC Package Code | 71399-4458-6 |
|---|---|
| Billing NDC | 71399445806 |
| Package | 6 PATCH in 1 BOX (71399-4458-6) / 1 PATCH in 1 PATCH |
| Marketing Start Date | 2021-11-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |